Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
This Week In Space podcast: Episode 203 — China Rising - 2Top 15 Supportable Design Brands Coming out on top
- 3Relentless rise in carbon pollution from fossil fuels slightly dampens climate-fighting hopes
- 4Beating Wellbeing Difficulties: Individual Victories in Health
- 5James Webb Space Telescope watches our Milky Way galaxy's monster black hole fire out a flare
- Mexican Woman Accused of Assaulting Partner With Belt After He Refused Sex, Police Say
- SpaceX's 1st 'Version 3' Super Heavy Starship booster buckles under pressure during initial tests
- 6 Fun Urban areas For Seniors To Travel
- NASA's moon mission has begun — here's what's ahead for the Artemis II astronauts
- The best movies to watch this holiday season: Stream 'A Christmas Story Christmas,' revisit 'The Night Before' and discover 'The Baltimorons'
- My Dad Can't Travel Like He Used to, but Slowing Down Doesn't Mean Stopping
- From Overpowered to Coordinated: Individual Accounts of Cleaning up
- Eat Well, Live Well: An Extensive Manual for Smart dieting and Sustenance
- A Couple of Modest Guitars for 2024
